This inventor holds 3 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2014-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Osaka, JP (2014)
- Nara, JP (2018)
Company Filing History:
Years Active: 2014-2018
Title: The Innovations of Makoto Fukuta
Introduction
Makoto Fukuta is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of 3 patents. His work focuses on developing innovative drug formulations that enhance the stability and efficacy of pharmaceutical preparations.
Latest Patents
Fukuta's latest patents include a pharmaceutical preparation containing copolyvidone. This stabilized preparation comprises an unstable drug in a polyethylene glycol-containing formulation, with a coating agent made of copolyvidone instead of polyethylene glycol. Another notable patent is for a tablet containing a hardly soluble active ingredient. This tablet demonstrates regulated variation in dissolution from lot to lot and contains a specific percentage of (S)−N-[2-(1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl)ethyl]propionamide, magnesium stearate, and hydroxypropylcellulose.
Career Highlights
Makoto Fukuta is currently associated with Takeda Pharmaceutical Company Limited, a leading global pharmaceutical company. His work at Takeda has allowed him to focus on innovative drug delivery systems and formulations that address various medical needs.
Collaborations
Fukuta has collaborated with esteemed colleagues such as Shigeyuki Marunaka and Hajime Ishida. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Makoto Fukuta's contributions to pharmaceutical innovations highlight his expertise and dedication to improving drug formulations. His patents reflect a commitment to enhancing the stability and effectiveness of medications, making a significant impact in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
